Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Autolus Therapeutics plc
| Metric | Autolus Therapeutics plc AUTLHealthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $75M |
| Net income (latest) | −$288M |
| Operating margin | −358.9% |
| Net margin | −381.4% |
| Return on equity | −161.4% |
| Return on assets | −48.8% |
| Return on capital (ROCE) | −52.5% |
| Debt / equity | 2.31× |
| Revenue growth (YoY) | 644.9% |
| Altman Z″ (distress) | -6.27 |
| Accruals / assets | −0.7% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.